Literature DB >> 32820261

Evidence lags behind excitement over blood plasma as a coronavirus treatment.

Heidi Ledford.   

Abstract

Entities:  

Keywords:  Immunology; Infection; Medical research; SARS-CoV-2

Mesh:

Substances:

Year:  2020        PMID: 32820261     DOI: 10.1038/d41586-020-02324-2

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  1 in total

1.  SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.

Authors:  Arturo Casadevall; Michael J Joyner; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

  1 in total
  1 in total

1.  The art of the possible in approaching efficacy trials for COVID19 convalescent plasma.

Authors:  Daniele Focosi; Albert Farrugia
Journal:  Int J Infect Dis       Date:  2020-10-30       Impact factor: 3.623

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.